文献速递脑血管病

脑血栓联合组学分析:识别心源性卒中起源的新分子方法

Combined Omic Analyzes of Cerebral Thrombi: A New Molecular Approach to Identify Cardioembolic Stroke Origin.
PubMed 文献 · Stroke · 2021-05-21

本研究对ThrombiOMIC队列中59例经机械取栓的卒中患者脑血栓进行蛋白质组学和代谢组学分析,比较心源性栓塞型与动脉粥样硬化血栓型卒中的分子特征。联合组学特征预测心源性卒中的AUC为0.996(95%CI 0.984–1),显著高于血浆BNP水平(AUC 0.803)。联合组学分析是预测心源性卒中病因的有前景的分子方法。

要点

  • 脑血栓联合蛋白质组学和代谢组学特征预测心源性卒中的AUC达0.996。
  • 联合组学诊断性能显著优于血浆BNP水平(AUC 0.803)。
  • 该分子方法有望改善心源性卒中的病因诊断和二级预防策略。

核心结论

  • 联合蛋白质组学和代谢组学分析取出的脑血栓是预测心源性卒中病因的非常有前景的分子方法。
  • 联合组学特征诊断性能显著高于经典预测指标如血浆BNP水平。

研究设计与样本

  • 本研究为试点研究,纳入ThrombiOMIC队列中59例急性期经机械取栓再通的卒中患者。
  • 根据ASCOD表型(最高因果等级)将患者分为心源性栓塞型(34例)和动脉粥样硬化血栓型(7例)。
  • 对取出的脑血栓进行非靶向蛋白质组学和代谢组学分析,分别或联合使用组学结果构建特征。
  • 采用ROC曲线下面积两两比较,将组学特征与经典心源性卒中预测指标进行对比。

主要发现

  • 蛋白质组学结果预测心源性卒中的AUC为0.945(95%CI 0.871–1)。
  • 代谢组学结果预测心源性卒中的AUC为0.836(95%CI 0.714–0.958)。
  • 联合组学特征预测心源性卒中的AUC为0.996(95%CI 0.984–1)。
  • 联合组学特征诊断性能显著高于血浆BNP水平(AUC 0.803,95%CI 0.629–0.976)。

临床怎么用

  • 对于经机械取栓的卒中患者,可考虑对取出的血栓进行联合蛋白质组学和代谢组学分析,以辅助心源性卒中的病因诊断。
  • 该分子方法有望改善隐源性卒中特别是阵发性心房颤动相关卒中的二级预防决策。

局限性

  • 本研究为试点研究,样本量较小(共59例,中心源性34例、动脉粥样硬化血栓型7例)。
  • 组学特征与经典预测指标的对比基于小样本,结果需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The diagnosis of cardioembolic stroke can be challenging for patient management in secondary stroke prevention, particularly in the case of covert paroxysmal atrial fibrillation. The molecular composition of a cerebral thrombus is related to its origin. Therefore, proteomic and metabolomic analyses of the retrieved thrombotic material should allow the identification of biomarkers or signatures to improve the etiological diagnosis of stroke. METHODS: In this pilot study, the proteome and metabolome of cerebral thrombi from atherothrombotic and cardioembolic stroke patients were studied according to ASCOD phenotyping (A: atherosclerosis; S: small-vessel disease; C: cardiac pathology; O: other causes; D: dissection), with the highest causality grade, from the ThrombiOMIC cohort (consecutive patients with stroke recanalized by mechanical thrombectomy in an acute phase). Proteomic and metabolomic results were used separately or combined, and the obtained omic signatures were compared with classical cardioembolic stroke predictors using pairwise comparisons of the area under receiver operating characteristics. RESULTS: Among 59 patients of the ThrombiOMIC cohort, 34 patients with stroke showed a cardioembolic phenotype and 7 had an atherothrombotic phenotype. Two thousand four hundred fifty-six proteins and 5019 molecular features of the cerebral thrombi were identified using untargeted proteomic and metabolomic approaches, respectively. Area under receiver operating characteristics to predict the cardioembolic origin of stroke were calculated using the proteomic results (0.945 [95% CI, 0.871–1]), the metabolomic results (0.836 [95% CI, 0.714–0.958]), and combined signatures (0.996 [95% CI, 0.984–1]). The diagnostic performance of the combined signatures was significantly higher than that of classical predictors such as the plasmatic BNP (B-type natriuretic peptide) level (area under receiver operating characteristics, 0.803 [95% CI, 0.629–0.976]). CONCLUSIONS: The combined proteomic and metabolomic analyses of retrieved cerebral thrombi is a very promising molecular approach to predict the cardioembolic cause of stroke and to improve secondary stroke prevention strategies.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Suissa L, Guigonis JM, Graslin F, et al. Combined Omic Analyzes of Cerebral Thrombi: A New Molecular Approach to Identify Cardioembolic Stroke Origin. Stroke. 2021. PMID: 34015939. doi:10.1161/STROKEAHA.120.032129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。